Bringing GC–MS profiling of steroids into clinical applications
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Abnormalities of steroid biosynthesis and excretion are responsible for the development and prevention of endocrine disorders, such as metabolic syndromes, cancers, and neurodegenerative diseases. Due to their biochemical roles in endocrine system, qualitative and quantitative analysis of steroid hormones in various biological specimens is needed to elucidate their altered expression. Mass spectrometry (MS)‐based steroid profiling can reveal the states of metabolites in biological systems and provide comprehensive insights by allowing comparisons between metabolites present in cells, tissues, or organisms. In addition, the activities of many enzymes related to steroid metabolism often lead to hormonal imbalances that have serious consequences, and which are responsible for the progress of hormone‐dependent diseases. In contrast to immunoaffinity‐based enzyme assays, MS‐based methods are more reproducible in quantification. In particular, high‐resolution gas chromatographic (GC) separation of steroids with similar chemical structures can be achieved to provide rapid and reproducible results with excellent purification. GC–MS profiling therefore has been widely used for steroid analysis, and offers the basis for techniques that can be applied to large‐scale clinical studies. Recent advances in analytical technologies combined with inter‐disciplinary strategies, such as physiology and bioinformatics, will help in understanding the biochemical roles of steroid hormones. Therefore, comprehensive analytical protocols in steroid analysis for different research purposes may contribute to the elucidation of complex metabolic processes relevant to steroid function in many endocrine disorders, and in the identification of diagnostic biomarkers. © 2014 Wiley Periodicals, Inc. Mass Spec Rev 34: 219–236, 2015.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The development of androgen-independent prostate cancer.
Feldman, B. J., & Feldman, D. (2001) · Nature reviews. Cancer · doi:10.1038/35094009 · Cited by 2,326 · cited 1×
“Although effective androgen-independent prostate cancer therapies have been explored (Feldman & Feldman, 2001), standard metastatic prostate cancer diagnosis and therapy includes the inhibition of androgen production and blockade of androgen receptor (AR) signaling (Hsing, Reichardt, & Stanczyk,…”
Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis
Khera, A. V., Cuchel, M., de la Llera-Moya, M., Rodrigues, A., Burke, M. F., Jafri, K., French, B. C., Phillips, J. A., Mucksavage, M. L., Wilensky, R. L., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1001689 · Cited by 1,943 · cited 1×
“Cholesterol is the major component of atherosclerotic plaque, and its accumulation within the plaque occurs when cholesterol influx into the arterial wall exceeds cholesterol efflux (Khera et al., 2011).”
Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones
Payne, A. H., & Hales, D. B. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0030 · Cited by 1,766
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins
Ray, S., Britschgi, M., Herbert, C., Takeda-Uchimura, Y., Boxer, A., Blennow, K., Friedman, L. F., Galasko, D. R., Jutel, M., Karydas, A., et al. (2007) · Nature Medicine · doi:10.1038/nm1653 · Cited by 1,048 · cited 1×
“Statistical clustering offers one such approach, and has been utilized to support genomic and proteomic studies (Rhodes & Chinnaiyan, 2005; Ivshina et al., 2006; Ray et al., 2007).”
Brown, M. S., Ho, Y. K., & Goldstein, J. L. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70568-7 · Cited by 722
Congenital adrenal hyperplasia.
Merke, D. P., & Bornstein, S. R. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66736-0 · Cited by 628
Profiling steroid hormones and urinary steroids
Shackleton, C. H. L. (1986) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)80683-0 · Cited by 291
Urinary free cortisone and the assessment of 11β‐hydroxysteroid dehydrogenase activity in man
Palermo, M., Shackleton, C. H. L., Mantero, F., & Stewart, P. M. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.00853.x · Cited by 276 · cited 4×
“Based on previous data (Mantero et al., 1996; Palermo et al., 1996b), however, these two patients could not be diagnosed with either AME type 1 or type 2.”
InfluentialAdvantages and challenges of mass spectrometry assays for steroid hormones
Stanczyk, F. Z., & Clarke, N. J. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.05.001 · Cited by 265
Low Serum Testosterone and Estradiol Predict Mortality in Elderly Men
Tivesten, A., Vandenput, L., Labrie, F., Karlsson, M. K., Ljunggren, O., Mellström, D., & Ohlsson, C. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2650 · Cited by 243
Cited by
Wudy, S. A., Schuler, G., Sánchez-Guijo, A., & Hartmann, M. F. (2018) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.09.003 · Cited by 236
Shackleton, C., Pozo, O. J., & Marcos, J. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00135 · Cited by 75
“Other types of sorbents have been tested for the profiling of steroids, such as pH-durable copolymeric sorbents with combinations of hydrophilic and lipophilic groups [30].”
BackgroundMetabolic changes in serum steroids for diagnosing and subtyping Cushing’s syndrome
Ahn, C. H., Lee, C., Shim, J., Kong, S. H., Kim, S.-J., Kim, Y. H., Lee, K. E., Shin, C. S., Kim, J. H., & Choi, M. H. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.105856 · Cited by 21
Self-citation
Metadata
- Authors
- Choi, M. H., & Chung, B. C.
- Venue
- Mass Spectrometry Reviews
- Publisher
- Wiley
- Published
- 2014-06-25
- Volume
- 34
- Issue
- 2
- Pages
- 219-236
- ISSN
- 0277-7037 (ISSN-L)
- 1098-2787
- OpenAlex
- W1583168199
- Cited by
- 39
- References
- 16
- FWCI
- 1.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.